Developer docs
API playgroundTry for free, no card

Search company profiles

Galenpharma

Full company profile

uuid000iwtu

Namestring
Galenpharma
Legal namestring
GALENpharma GmbH
Websiteurl
galenpharma.de
Company typeenum
Private
Founded yearint
1985
Descriptiontext

GALENpharma GmbH is a German family-owned pharmaceutical company founded in 1985 in Kiel by Dr. med. Otto Paulsen and his son, pharmacist Jan Paul Paulsen. The company specializes in galenic formulations — the science of compounding drugs into usable dosage forms — and is headquartered at Wittland 13, Kiel. Its stated core competency is corticosteroids, where it claims the broadest range of formulations in Germany spanning topical (creams, ointments, solutions, lotions, gels), oral (tablets, soft capsules), nasal sprays, and parenteral (injectable) presentations. Beyond corticosteroids, the portfolio covers dermatology (HydroGalen hydrocortisone cream, ClotriGalen clotrimazole antifungal cream and pumpspray, Amofin amorolfine nail lacquer), allergy (MomeAllerg mometasone nasal spray, DuoAllerg azelastine/fluticasone combination spray), local anesthesia (LIDOGALEN lidocaine cream, Lidoproct lidocaine rectal ointment), testosterone replacement therapy, and vitamin D supplementation (Vit. D3 GALEN).

The company sells both prescription (Rx) and over-the-counter (OTC) medications through the German public pharmacy (Apotheken) channel, with no documented exports beyond the DACH region. It targets healthcare professionals — physicians and pharmacists — as selection partners, providing product information through a DocCheck-protected Fachkreise (HCP) portal in compliance with German pharmaceutical advertising regulations. End users are patients in dermatology, urology, endocrinology, allergology, orthopedics, pediatrics, oncology, and general practice. Marketing is supported by Google Ads, Matomo web analytics, Google Tag Manager, and Proven Expert review management.

The business model is straightforward pharmaceutical product sales through wholesale-to-pharmacy distribution. Pricing is determined by German pharmaceutical market regulations rather than company-set pricing, and is not publicly disclosed. Revenue figures are not disclosed; the company is privately held with no external funding, no parent company, no subsidiaries, no M&A history, and no public financial reporting. Current management comprises Jan Paul Paulsen (founder's son, managing director) and Dr. Hanns Soblik (representative). Headcount is in the 11–50 range.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKiel, Germany
HQ citystring
Kiel
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
topical corticosteroids, dermatological products, galenic formulations, pharmaceutical manufacturing, allergy medications
Industry4 codes
PRIMARYHLAIADAE
Dermatology & Topical Skin Treatments
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIADAC
Allergy, Sinus & Respiratory (Non-Asthma)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIABAE
Topical & Dermatology Generics
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Dermatological Pharmaceuticals
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical product sales
TypeHardware Sales
Description

GALENpharma generates revenue through the development, manufacturing, and supply of pharmaceutical medications. Their product portfolio includes prescription (Rx) and over-the-counter (OTC) medications distributed through public pharmacies in Germany. The company offers a broad range of topical, oral, and parenteral medications primarily focused on corticosteroids, dermatological products, allergy treatments, testosterone preparations, and essential dermatological treatments.

galenpharma.de
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

GALENpharma GmbH develops, manufactures, and distributes topical, oral, and parenteral pharmaceutical medications in Germany. Its core competency is galenic formulations, with the broadest range of corticosteroid formulations in Germany covering creams, ointments, solutions, lotions, gels, tablets, soft capsules, nasal sprays, and injectables. The portfolio additionally includes dermatological products, allergy treatments, testosterone preparations, antifungal medications, local anesthetics, and vitamin D supplements, available as both prescription (Rx) and over-the-counter (OTC) products.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

GALENpharma GmbH is a German pharmaceutical company founded in 1985, based in Kiel, specializing in the development, manufacture, and distribution of topical, oral, and parenteral medications. The company's core competencies lie in corticosteroids, with the broadest range of corticosteroid formulations in Germany, complemented by dermatological products, allergy treatments, testosterone preparations, and over-the-counter medications. The portfolio includes allergy treatments (MomeAllerg® NASENSPRAY, DuoAllerg® NASENSPRAY), anti-inflammatory dermatologicals (HydroGalen® akut CREME), antifungals (ClotriGalen® CREME/PUMPSPRAY, Amofin® Nagellack), local anesthetics (LIDOGALEN® CREME, Lidoproct® Rektalsalbe), and vitamin supplements (Vit. D3 GALEN®). The company markets through pharmacies and serves medical specialties including dermatology, urology, endocrinology, allergology, orthopedics, pediatrics, oncology, and general practice.

Product and service9 records
1MomeAllerg® NASENSPRAY
CategoryAllergy / Nasal Corticosteroid
Description

Mometasone furoate nasal spray (50 µg/spray) for symptomatic treatment of seasonal allergic rhinitis in adults. Provides long-lasting relief with once-daily targeted nasal action.

2DuoAllerg® NASENSPRAY
CategoryAllergy / Combination Nasal Spray
Description

Combination nasal spray containing azelastine hydrochloride and fluticasone propionate for treatment of moderate to severe seasonal allergic rhinitis when monotherapy with an intranasal antihistamine or corticosteroid is insufficient.

3HydroGalen® akut CREME
CategoryTopical Corticosteroid / Dermatological
Description

Hydrocortisone 5 mg/g anti-inflammatory cream for short-term (maximum 2 weeks) treatment of inflammatory, allergic, or pruritic skin conditions responding to mild topical corticosteroids.

4ClotriGalen® CREME
CategoryAntifungal / Topical
Description

Topical antifungal cream containing clotrimazole for treatment of skin fungal infections caused by dermatophytes, yeasts, and molds; also effective against Corynebacterium minutissimum.

5ClotriGalen® PUMPSPRAY
CategoryAntifungal / Topical Spray
Description

Clotrimazole 10 mg/ml topical solution spray (40 ml) for treatment of skin fungal infections. Antifungal medication with broad-spectrum activity against fungi, yeasts, and bacteria.

6Amofin® Nagellack
CategoryAntifungal / Nail Lacquer
Description

Nail lacquer containing 5% amorolfine hydrochloride for treatment of nail fungal infections. Waterproof, colorless lacquer with 7-day duration of action, applied once weekly.

7LIDOGALEN® CREME
CategoryLocal Anesthetic / Topical
Description

Topical anesthetic cream containing 40 mg/g lidocaine for pain control prior to minor procedures such as injections, microneedling, and tattoo removal. Provides approximately 2 hours of pain relief with 30-minute exposure time. Suitable for infants from 1 month of age.

8Lidoproct® Rektalsalbe
CategoryLocal Anesthetic / Rectal
Description

Rectal ointment containing 50 mg/g lidocaine for localized treatment of pain and itching in the anal area, including hemorrhoids and anal fissures. Includes applicator for targeted application.

9Vit. D3 GALEN® 1.000 I.E.
CategoryVitamin Supplement / OTC
Description

Colecalciferol (Vitamin D3) 1,000 I.E. soft capsule for treatment and prevention of vitamin D deficiency in adults and adolescents. Supports bone health and immune system function. Made from bovine gelatin (halal certified).

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

DocCheck provides healthcare professional authentication for GALENpharma's Fachkreise (professional) portal. Access to protected professional information requires DocCheck login credentials. This ensures compliance with regulations restricting certain product information to healthcare professionals only.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German specialty pharmaceutical company with a strong focus on dermatology, allergy, and OTC products, very comparable to GALENpharma's therapeutic mix and German pharmacy channel.

TypeBroad incumbent
Description

Large German-headquartered generic and specialty pharma with a broad dermatology, allergy, and OTC portfolio overlapping GALENpharma's therapeutic areas via German pharmacy distribution.

TypeBroad incumbent
Description

Major German generics manufacturer (Sandoz/Novartis) active across dermatology, allergy, and OTC categories through the same Apotheken channel as GALENpharma.

TypeBroad incumbent
Description

Prominent German generics brand (Teva) competing in many of the same active ingredients (e.g., mometasone, hydrocortisone, clotrimazole) and the same pharmacy distribution channel.

5Kade Pharma / Besins Healthcare Germany
TypeDirect peer
Description

Mid-sized German specialty pharma with comparable dermatology, gynecology/urology, and OTC offerings distributed through German pharmacies.

6Strathmann GmbH & Co. KG
TypeDirect peer
Description

German specialty pharmaceutical company with overlapping dermatology and OTC product portfolios, distributed via the German pharmacy channel.

7Biologische Heilmittel Heel GmbH
TypeDirect peer
Description

German pharmaceutical manufacturer with a comparable dermatology and immunology-adjacent portfolio targeting physicians and pharmacies in Germany.

TypeBroad incumbent
Description

Diversified German incumbent with a strong dermatology and allergy OTC portfolio (e.g., Bepanthen, Claritin) competing directly with several GALENpharma SKUs in pharmacies.

TypeRegional player
Description

European dermatology-focused specialty pharma with comparable therapeutic-area focus; serves Germany through affiliates and partners but is headquartered in Spain.

TypeDirect peer
Description

Mid-sized German specialty pharma with dermatology, gynecology, and OTC lines sold through German pharmacies — a close analogue in scale and channel.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Galenpharma

Dermatological Pharmaceuticalsgalenpharma.de

What Galenpharma does

GALENpharma GmbH is a German family-owned pharmaceutical company founded in 1985 in Kiel by Dr. med. Otto Paulsen and his son, pharmacist Jan Paul Paulsen. The company specializes in galenic formulations — the science of compounding drugs into usable dosage forms — and is headquartered at Wittland 13, Kiel. Its stated core competency is corticosteroids, where it claims the broadest range of formulations in Germany spanning topical (creams, ointments, solutions, lotions, gels), oral (tablets, soft capsules), nasal sprays, and parenteral (injectable) presentations. Beyond corticosteroids, the portfolio covers dermatology (HydroGalen hydrocortisone cream, ClotriGalen clotrimazole antifungal cream and pumpspray, Amofin amorolfine nail lacquer), allergy (MomeAllerg mometasone nasal spray, DuoAllerg azelastine/fluticasone combination spray), local anesthesia (LIDOGALEN lidocaine cream, Lidoproct lidocaine rectal ointment), testosterone replacement therapy, and vitamin D supplementation (Vit. D3 GALEN).

The company sells both prescription (Rx) and over-the-counter (OTC) medications through the German public pharmacy (Apotheken) channel, with no documented exports beyond the DACH region. It targets healthcare professionals — physicians and pharmacists — as selection partners, providing product information through a DocCheck-protected Fachkreise (HCP) portal in compliance with German pharmaceutical advertising regulations. End users are patients in dermatology, urology, endocrinology, allergology, orthopedics, pediatrics, oncology, and general practice. Marketing is supported by Google Ads, Matomo web analytics, Google Tag Manager, and Proven Expert review management.

The business model is straightforward pharmaceutical product sales through wholesale-to-pharmacy distribution. Pricing is determined by German pharmaceutical market regulations rather than company-set pricing, and is not publicly disclosed. Revenue figures are not disclosed; the company is privately held with no external funding, no parent company, no subsidiaries, no M&A history, and no public financial reporting. Current management comprises Jan Paul Paulsen (founder's son, managing director) and Dr. Hanns Soblik (representative). Headcount is in the 11–50 range.

Galenpharma firmographics

Firmographics
Name
Galenpharma
Legal name
GALENpharma GmbH
Website
https://galenpharma.de
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Galenpharma industry classification

Industry
Product category
Dermatological Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIADAE
Dermatology & Topical Skin Treatments
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIADAC
Allergy, Sinus & Respiratory (Non-Asthma)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
SECONDARYHLAIABAE
Topical & Dermatology Generics

Keywords

  • Topical corticosteroids
  • Dermatological products
  • Galenic formulations
  • Pharmaceutical manufacturing
  • Allergy medications

Where Galenpharma is headquartered

Location

Headquarters

HQ city
Kiel
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Galenpharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Pharmaceutical product sales: GALENpharma generates revenue through the development, manufacturing, and supply of pharmaceutical medications. Their product portfolio includes prescription (Rx) and over-the-counter (OTC) medications distributed through public pharmacies in Germany. The company offers a broad range of topical, oral, and parenteral medications primarily focused on corticosteroids, dermatological products, allergy treatments, testosterone preparations, and essential dermatological treatments.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Galenpharma product offering

Product offering

Core offering

GALENpharma GmbH develops, manufactures, and distributes topical, oral, and parenteral pharmaceutical medications in Germany. Its core competency is galenic formulations, with the broadest range of corticosteroid formulations in Germany covering creams, ointments, solutions, lotions, gels, tablets, soft capsules, nasal sprays, and injectables. The portfolio additionally includes dermatological products, allergy treatments, testosterone preparations, antifungal medications, local anesthetics, and vitamin D supplements, available as both prescription (Rx) and over-the-counter (OTC) products.

Product overview

GALENpharma GmbH is a German pharmaceutical company founded in 1985, based in Kiel, specializing in the development, manufacture, and distribution of topical, oral, and parenteral medications. The company's core competencies lie in corticosteroids, with the broadest range of corticosteroid formulations in Germany, complemented by dermatological products, allergy treatments, testosterone preparations, and over-the-counter medications. The portfolio includes allergy treatments (MomeAllerg® NASENSPRAY, DuoAllerg® NASENSPRAY), anti-inflammatory dermatologicals (HydroGalen® akut CREME), antifungals (ClotriGalen® CREME/PUMPSPRAY, Amofin® Nagellack), local anesthetics (LIDOGALEN® CREME, Lidoproct® Rektalsalbe), and vitamin supplements (Vit. D3 GALEN®). The company markets through pharmacies and serves medical specialties including dermatology, urology, endocrinology, allergology, orthopedics, pediatrics, oncology, and general practice.

Differentiator

Problem solved

Functional benefit

Products and services

  • MomeAllerg® NASENSPRAY Mometasone furoate nasal spray (50 µg/spray) for symptomatic treatment of seasonal allergic rhinitis in adults. Provides long-lasting relief with once-daily targeted nasal action.
  • DuoAllerg® NASENSPRAY Combination nasal spray containing azelastine hydrochloride and fluticasone propionate for treatment of moderate to severe seasonal allergic rhinitis when monotherapy with an intranasal antihistamine or corticosteroid is insufficient.
  • HydroGalen® akut CREME Hydrocortisone 5 mg/g anti-inflammatory cream for short-term (maximum 2 weeks) treatment of inflammatory, allergic, or pruritic skin conditions responding to mild topical corticosteroids.
  • ClotriGalen® CREME Topical antifungal cream containing clotrimazole for treatment of skin fungal infections caused by dermatophytes, yeasts, and molds; also effective against Corynebacterium minutissimum.
  • ClotriGalen® PUMPSPRAY Clotrimazole 10 mg/ml topical solution spray (40 ml) for treatment of skin fungal infections. Antifungal medication with broad-spectrum activity against fungi, yeasts, and bacteria.
  • Amofin® Nagellack Nail lacquer containing 5% amorolfine hydrochloride for treatment of nail fungal infections. Waterproof, colorless lacquer with 7-day duration of action, applied once weekly.
  • LIDOGALEN® CREME Topical anesthetic cream containing 40 mg/g lidocaine for pain control prior to minor procedures such as injections, microneedling, and tattoo removal. Provides approximately 2 hours of pain relief with 30-minute exposure time. Suitable for infants from 1 month of age.
  • Lidoproct® Rektalsalbe Rectal ointment containing 50 mg/g lidocaine for localized treatment of pain and itching in the anal area, including hemorrhoids and anal fissures. Includes applicator for targeted application.
  • Vit. D3 GALEN® 1.000 I.E. Colecalciferol (Vitamin D3) 1,000 I.E. soft capsule for treatment and prevention of vitamin D deficiency in adults and adolescents. Supports bone health and immune system function. Made from bovine gelatin (halal certified).

Companies that use Galenpharma

Customer profile

Segments4 records

Ideal customer profiles2 records

Galenpharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Galenpharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • DocCheckcoreTechnology or IntegrationDocCheck provides healthcare professional authentication for GALENpharma's Fachkreise (professional) portal. Access to protected professional information requires DocCheck login credentials. This ensures compliance with regulations restricting certain product information to healthcare professionals only.

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

Galenpharma competitors and assessment

Company assessment

Direct peers

  • Dermapharm Holding SE: German specialty pharmaceutical company with a strong focus on dermatology, allergy, and OTC products, very comparable to GALENpharma's therapeutic mix and German pharmacy channel.
  • Kade Pharma / Besins Healthcare Germany: Mid-sized German specialty pharma with comparable dermatology, gynecology/urology, and OTC offerings distributed through German pharmacies.
  • Strathmann GmbH & Co. KG: German specialty pharmaceutical company with overlapping dermatology and OTC product portfolios, distributed via the German pharmacy channel.
  • Biologische Heilmittel Heel GmbH: German pharmaceutical manufacturer with a comparable dermatology and immunology-adjacent portfolio targeting physicians and pharmacies in Germany.
  • Dr. August Wolff GmbH & Co. KG Arzneimittel: Mid-sized German specialty pharma with dermatology, gynecology, and OTC lines sold through German pharmacies — a close analogue in scale and channel.

Broad incumbents

  • STADA Arzneimittel AG: Large German-headquartered generic and specialty pharma with a broad dermatology, allergy, and OTC portfolio overlapping GALENpharma's therapeutic areas via German pharmacy distribution.
  • Hexal AG: Major German generics manufacturer (Sandoz/Novartis) active across dermatology, allergy, and OTC categories through the same Apotheken channel as GALENpharma.
  • ratiopharm GmbH: Prominent German generics brand (Teva) competing in many of the same active ingredients (e.g., mometasone, hydrocortisone, clotrimazole) and the same pharmacy distribution channel.
  • Bayer AG (Consumer Health / Dermatology): Diversified German incumbent with a strong dermatology and allergy OTC portfolio (e.g., Bepanthen, Claritin) competing directly with several GALENpharma SKUs in pharmacies.

Regional players

  • Almirall S.A. European dermatology-focused specialty pharma with comparable therapeutic-area focus; serves Germany through affiliates and partners but is headquartered in Spain.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Galenpharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Galenpharma leadership team

Management profile

Number of profiles

Profiles2 records

Galenpharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Galenpharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Galenpharma

What does Galenpharma do?

GALENpharma GmbH develops, manufactures, and distributes topical, oral, and parenteral pharmaceutical medications in Germany. Its core competency is galenic formulations, with the broadest range of corticosteroid formulations in Germany covering creams, ointments, solutions, lotions, gels, tablets, soft capsules, nasal sprays, and injectables. The portfolio additionally includes dermatological products, allergy treatments, testosterone preparations, antifungal medications, local anesthetics, and vitamin D supplements, available as both prescription (Rx) and over-the-counter (OTC) products.

Is Galenpharma a public or private company?

Galenpharma is a private company. It is classified as family owned and is currently operating.

When was Galenpharma founded?

Galenpharma was founded in 1985. It employs 11 to 50 people.

Where is Galenpharma based?

Galenpharma is headquartered in Kiel, Germany, in the Europe region.

How does Galenpharma make money?

One revenue line is on record: pharmaceutical product sales.

Who are Galenpharma's main competitors?

Direct peers on record are Dermapharm Holding SE, Kade Pharma / Besins Healthcare Germany, Strathmann GmbH & Co. KG, Biologische Heilmittel Heel GmbH and Dr. August Wolff GmbH & Co. KG Arzneimittel. Broad incumbents are STADA Arzneimittel AG, Hexal AG, ratiopharm GmbH and Bayer AG (Consumer Health / Dermatology). Almirall S.A. is listed as a regional player.

Does Galenpharma have an API?

No public API is recorded for Galenpharma.

What industry is Galenpharma in?

Galenpharma's product category is Dermatological Pharmaceuticals. Its primary akta.pro industry code is HLAIADAE, Dermatology & Topical Skin Treatments, with a secondary code of HLAIADAC, Allergy, Sinus & Respiratory (Non-Asthma). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales